Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor-Reference-Cited by-同舟云学术

Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor

Published:2017-05-08 Issue:6 Volume:69 Page:783-793
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Hamann Philip¹,Holland Richard²,Hyrich Kimme³,Pauling John D.¹,Shaddick Gavin⁴,Nightingale Alison⁴,McHugh Neil⁴

Affiliation:

1. University of Bath, Claverton Down, and Royal United Hospitals, Royal National Hospital for Rheumatic Diseases; Upper Borough Walls Bath UK

2. Royal United Hospitals, Royal National Hospital for Rheumatic Diseases; Upper Borough Walls Bath UK

3. Arthritis Research UK Centre for Epidemiology, Manchester Academic Health Science Centre, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, and University of Manchester Partnership; Manchester UK

4. University of Bath; Claverton Down, Bath UK

Funder

British Society for Rheumatology

Publisher

Wiley

Subject

Rheumatology

Reference35 articles.

1. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial;Grigor;Lancet,2004

2. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial;Goekoop-Ruiterman;Arthritis Rheum,2005

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

4. Predictors for remission in rheumatoid arthritis patients: a systematic review;Katchamart;Arthritis Care Res (Hoboken),2010

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study;Rheumatology and Therapy;2024-08-23

2. PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs;RMD Open;2024-05

3. Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry;Arthritis Research & Therapy;2023-05-22

4. Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study;Clinical Rheumatology;2023-02-17

5. Orthorexia Nervosa Practices in Rheumatoid Arthritis: The DORA Study;Nutrients;2023-01-31